FFA
DGX icon

Farther Finance Advisors’s Quest Diagnostics DGX Stock Holding History

Farther Finance Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77M Buy
8,362
+5,824
+229% +$1.14M 0.01% 809
2026
Q1 		$502K Sell
2,538
-105
-4% -$20.4K ﹤0.01% 1390
2025
Q4 		$459K Sell
2,643
-221
-8% -$40.2K ﹤0.01% 1363
2025
Q3 		$546K Buy
2,864
+208
+8% +$36.9K 0.01% 1031
2025
Q2 		$477K Sell
2,656
-282
-10% -$49K 0.01% 924
2025
Q1 		$497K Sell
2,938
-1,249
-30% -$205K 0.01% 788
2024
Q4 		$632K Sell
4,187
-44
-1% -$6.84K 0.02% 511
2024
Q3 		$657K Sell
4,231
-420
-9% -$62.7K 0.02% 487
2024
Q2 		$638K Buy
4,651
+2,617
+129% +$358K 0.03% 401
2024
Q1 		$274K Buy
2,034
+1,475
+264% +$191K 0.02% 582
2023
Q4 		$77.1K Buy
559
+34
+6% +$4.47K 0.01% 883
2023
Q3 		$64K Buy
525
+20
+4% +$2.67K 0.01% 703
2023
Q2 		$71K Sell
505
-36
-7% -$4.96K 0.02% 560
2023
Q1 		$76.5K Buy
541
+96
+22% +$13.7K 0.02% 482
2022
Q4 		$69.6K Buy
+445
New +$63.9K 0.03% 413

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Farther Finance Advisors's DGX Position: Q2 2026 in Review

Farther Finance Advisors increased its Quest Diagnostics (DGX) stake by 229% in Q2 2026, buying an estimated $1.14M and bringing the position to 8,362 shares worth $1.77M. The position accounts for 0.01% of the portfolio, ranked #809.

Farther Finance Advisors first reported a position in DGX in Q4 2022 and has held it in 15 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Farther Finance Advisors held 8,362 shares of Quest Diagnostics worth $1.77M as of Q2 2026.
  • Farther Finance Advisors bought 5,824 Quest Diagnostics shares in Q2 2026, an estimated $1.14M.
  • Quest Diagnostics made up 0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #809 holding.
  • Farther Finance Advisors first reported a position in Quest Diagnostics in Q4 2022 and has held it in 15 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.